[Federal Register Volume 73, Number 125 (Friday, June 27, 2008)]
[Notices]
[Page 36573]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-14585]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 22, 2008, Norac Inc., 405 
S. Motor Avenue, P.O. Box 577, Azusa, California 91702-3232, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Gamma Hydroxybutyric Acid 
(2010), a basic class of controlled substance listed in schedule I.
    The company plans to manufacture the listed controlled substance in 
bulk for sale to its customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such a substance, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Federal Register 
Representative (ODL), Washington, DC 20537, or any being sent via 
express mail should be sent to Drug Enforcement Administration, Office 
of Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than August 26, 2008.

    Dated: June 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-14585 Filed 6-26-08; 8:45 am]
BILLING CODE 4410-09-P